Cas:81342-98-5 Bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolate]Cobalt(Ⅲ)Chloride manufacturer & supplier

We serve Chemical Name:Bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolate]Cobalt(Ⅲ)Chloride CAS:81342-98-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolate]Cobalt(Ⅲ)Chloride

Chemical Name:Bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolate]Cobalt(Ⅲ)Chloride
CAS.NO:81342-98-5
Synonyms:Bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolate]Cobalt(Ⅲ)Chloride
Molecular Formula:C30H32N8O2Cl3Co
Molecular Weight:701.92
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolate]Cobalt(Ⅲ)Chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolate]Cobalt(Ⅲ)Chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolate]Cobalt(Ⅲ)Chloride Use and application,Bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolate]Cobalt(Ⅲ)Chloride technical grade,usp/ep/jp grade.


Related News: The most frequently reported adverse events for anifrolumab in the TULIP-1 and TULIP-2 trials were upper respiratory tract infection, bronchitis, infusion-related reactions and herpes zoster. 6-(4-((2-fluorobenzyl)oxy)benzofuran-6-carboxamido)nicotinic acid manufacturers Johnson & Johnson’s COVID-19 vaccine presents greater benefits than it does safety risks, especially amid the quickly spreading Delta variant, a key CDC expert panel decided. However, the panel said that a ruling over the need for a booster added to all COVID shots will have to start with the FDA. 1,4,5-trihydroxy-3-methyl-2-methoxypentane suppliers Many specialty and biotech organizations are now relying on external service providers to minimize the costs of manufacturing and in-house development required to develop molecules for new drugs and their subsequent clinical trials, explains Saurabh Gurnurkar, executive director, UQUIFA. methyl (2S)-2-[(4-ethoxy-4-oxobutyl)amino]butanoate vendor & factory.